Related Experiment Videos
New factors secreted from islets expand β-cell mass
1Department of Metabolism & Endocrinology Juntendo University Graduate School of Medicine Tokyo Japan.
Journal of Diabetes Investigation
|May 21, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Transcriptional and temporal heterogeneity of developing α cells revealed by single-cell RNA sequencing.
Biochemical and biophysical research communications·2025
MyEveryCise: A method for everyday exercise using 'an activity of daily living' as a cue.
Journal of Alzheimer's disease : JAD·2025
The Beck Depression Inventory-II scores of adults with type 1 diabetes in Japan: Analysis using the Juntendo-Aso Type 1 Diabetes (JAT-1) Cohort.
Journal of diabetes investigation·2025
Role of glucagon in metabolic diseases.
Journal of diabetes investigation·2026
Accuracy, safety, and usability of a real-time continuous glucose monitoring system in pediatric diabetes management.
Journal of diabetes investigation·2026
Close relationship between β2-microglobulin and type 2 diabetes-associated peripheral neuropathy.
Journal of diabetes investigation·2026
Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Journal of diabetes investigation·2026
Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council.
Journal of diabetes investigation·2026
Extravascular distribution of factor IX-review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy.
Research and practice in thrombosis and haemostasis·2026
Simultaneous targeting of IL-10 and PD-(L)1 pathways with a bispecific anti-PD-L1/IL-10-trap antibody enhances T cell responses.
Molecular therapy. Oncology·2026
SARS-CoV-2-induced IgG repertoires shape T cell responses, microRNA regulation, and autoreactivity according to disease severity.
Journal of translational autoimmunity·2026